Finance

Beta
Ask
Lists
4LN2:FRA
Capricor Therapeutics Inc
€21.00
-1.64%
(-0.35) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4LN2...
Open
€20.60
High
€21.00
Low
€20.60
Mkt. cap
1.49B
Avg. vol.
87.00
Volume
0.00
52-wk high
€30.10
52-wk low
€3.73
No. of employees
231
Open
€20.60
High
€21.00
Low
€20.60
Mkt. cap
1.49B
Avg. vol.
87.00
Volume
0.00
52-wk high
€30.10
52-wk low
€3.73
No. of employees
231
News stories
From sources across the web
About Capricor Therapeutics Inc
CEOLinda Marban
Employees231
Founded2005
Headquarters-
SectorBiotechnology
Websitecapricor.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
22.05M
20.36M
23.13M
27.38M
Cost of revenue
22.05M
20.36M
23.13M
27.38M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.67M
5.92M
6.02M
9.40M
Operating expense
5.67M
5.92M
6.02M
9.40M
Total operating expenses
27.72M
26.28M
29.16M
36.77M
Operating income
-27.72M
-26.28M
-29.16M
-36.77M
Other non operating income
14.99K
6.74K
11.20K
8.14K
EBT including unusual items
-25.91M
-24.57M
-30.17M
-33.94M
EBT excluding unusual items
-25.91M
-24.56M
-30.17M
-33.86M
Income tax expense
-
-
1.60K
-
Effective tax rate
-
-
-0.01%
-
Other operating expenses
-
-
-
-
Net income
-25.91M
-24.57M
-30.17M
-33.94M
Net profit margin
-
-
-
-
Earnings per share
-0.57
-0.54
-0.62
-0.59
Interest and investment income
1.79M
1.71M
2.02M
2.90M
Interest expense
-
-
-3.05M
-
Net interest expenses
1.79M
1.71M
-1.02M
2.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.23M
-25.79M
-28.65M
-36.24M
Gain or loss from assets sale
-
6.85K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer